A new study by Christian Medical College (CMC) Vellore has suggested that mixing vaccines for COVID-19 shows a mixed result depending on the initial vaccination schedule, presenting programmatic challenges moving forward. The government, in light of this newfound data, has suggested that they may not allow booster doses of COVID-19 vaccines other than the one …
India has commenced paediatric trials for Covaxin, its indigenously-manufactured vaccine against COVID-19. Covaxin, manufactured by Hyderabad-based firm Bharat Biotech, is one of four vaccines authorised for use in India alongside Covishield (produced by the Serum Institute of India on license from AstraZeneca), the Russian-manufactured Sputnik-V, and the Moderna vaccine. Bharat Biotech announced last month that …
India’s homegrown COVID-19 vaccine Covaxin is to face scrutiny from the World Health Organization (WHO) on June 23rd when a pre-submission hearing will be held. Manufacturer Bharat Biotech received the WHO’s nod for its expression of interest for emergency use listing of Covaxin, in a step commentators regard as moving the vaccine closer to securing …
Covaxin, India’s homegrown COVID-19 vaccine candidate, has shown promising results in interim phase-III trials. The vaccine, manufactured by Hyderabad, Telangana-headquartered firm Bharat Biotech, demonstrated an almost 81 percent interim clinical efficacy according to the company following the release of results from the interim phase-III trials on Wednesday. “Covaxin demonstrates high clinical efficacy trend against COVID-19 …
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
